Founded in 2001, Sihuan Pharmaceutical Holdings Group Ltd ("Sihuan Pharmaceutical" or the "Company") has become the largest cardio-cerebral vascular ("CCV") drug manufacturer in China's prescription drug market by market share since 2007. Sihuan Pharmaceutical is an integrated corporate with its own production, research and development ("R&D") and marketing capacities. The success of the Group can be attributed to its differentiated and proven sales and marketing model, extensive nationwide distribution network, diversified product portfolio, and strong R&D capabilities. The Group's current products encompass the top five medical therapeutic areas in China: cardiocerebral vascular system, central nervous system, metabolism, oncology and anti-infectives.

© Copyright 1996-20220232 irasia.com Ltd. All rights reserved.

DISCLAIMER: irasia.com Ltd makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd be liable for damages resulting from the use of the information provided on this website. TRADEMARK & COPYRIGHT: All intellectual property rights subsisting in the contents of this website belong to irasia.com Ltd or have been lawfully licensed to irasia.com Ltd for use on this website. All rights under applicable laws are hereby reserved. Reproduction of this website in whole or in part without the express written permission of irasia.com Ltd is strictly prohibited. TERMS OF USE: Please read the Terms of Use governing the use of our website.